EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitScoping ReviewOpen access · CC BY 4.0

Direct Oral Healthcare Costs Associated With Xerostomia and Hyposalivation: A Scoping Review and Annual Cost Synthesis

Mateus José Dutra iD, Manoela Domingues Martins iD, Naile Dame-Teixeira iD, Vivian Petersen Wagner iD

Oral Diseases · 2026-11-05

DOI: 10.1111/odi.70565 ↗

At a glance

Übersichtsarbeit in Oral Diseases, published online on 2026-11-05. Written by Mateus José Dutra and 3 co-authors. Institution: Department of Oral Diagnosis, Piracicaba Dental School, Universidade Estadual de Campinas, São Paulo, Brazil. 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Objective

To map the available evidence on direct oral healthcare costs associated with xerostomia and hyposalivation.

Methods

A scoping review was conducted following PRISMA‐ScR guidelines. Searches were performed in PubMed, Scopus, Embase, and Web of Science, with additional screening of gray literature. Studies reporting direct oral healthcare costs associated with xerostomia or/and hyposalivation were eligible. Reported costs were standardized to a common currency and price year. Exploratory annual cost scenarios were generated by combining reported unit costs with reported guideline‐based or hypothetical frequencies.

Results

Eight studies met the inclusion criteria. Six (75%) were conducted in the United States and two (25%) in the United Kingdom. Reported cost components included dental consultations, salivary stimulants and substitutes, restorative treatments, dental implants, fluoride applications, and management of oral infections. Evidence was heterogeneous in populations, etiologies, healthcare settings, cost components, and reporting methods. Illustrative base‐case scenarios ranged from USD 3296.08 to USD 10,414.51 per patient per year (USD 1791.23–5658.99 when hypothetical events and possible overlaps were excluded).

Conclusion

The evidence base is limited and heterogeneous. The exploratory annual synthesis provides an initial framework for mapping reported cost components but does not represent a definitive estimate of economic burden.

Subjects

Author keywords

Sjögren's syndromecosts and cost analysishead and neck neoplasmsxerostomia

Authors and institutions

  • Department of Oral Diagnosis, Piracicaba Dental School, Universidade Estadual de Campinas, São Paulo, Brazil.
  • Department of Oral Pathology, School of Dentistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
  • School of Health Sciences, University of Brasilia, Brasilia, Brazil.
  • Department of Oral Pathology, School of Dentistry, University of São Paulo, São Paulo, Brazil.

ORCID profiles: Mateus José Dutra, Manoela Domingues Martins, Naile Dame-Teixeira, Vivian Petersen Wagner

Funding

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Cite

APA

Dutra, M. J., Martins, M. D., Dame-Teixeira, N., & Wagner, V. P. (2026). Direct Oral Healthcare Costs Associated With Xerostomia and Hyposalivation: A Scoping Review and Annual Cost Synthesis. Oral Diseases. https://doi.org/10.1111/odi.70565

Vancouver

Dutra MJ, Martins MD, Dame-Teixeira N, Wagner VP. Direct Oral Healthcare Costs Associated With Xerostomia and Hyposalivation: A Scoping Review and Annual Cost Synthesis. Oral Diseases. 2026. doi:10.1111/odi.70565

BibTeX
@article{Dutra2026,
  author = {Dutra, Mateus José and Martins, Manoela Domingues and Dame-Teixeira, Naile and Wagner, Vivian Petersen},
  title = {Direct Oral Healthcare Costs Associated With Xerostomia and Hyposalivation: A Scoping Review and Annual Cost Synthesis},
  journal = {Oral Diseases},
  year = {2026},
  doi = {10.1111/odi.70565}
}
Start for free →